SCHEMBL4757864

SCHEMBL4757864

CCS(=O)(=O)Cc1cnc(NC(=O)c2ccccc2OC(C)OC(=O)C(C)(C)C)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 3/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
TSHR P16473 3/20 0.40
MAPK1 P28482 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 3/20 0.40
MAPT P10636 2/20 0.40
MLNR O43193 1/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
ADRB2 P07550 1/20 0.40
CHRM2 P08172 1/20 0.40
ADRB1 P08588 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757825 0.75 ALDH1A1 (0.46) ALDH1A1USP2LMNAGAAMEN1
SCHEMBL4757570 0.72 MEN1 (0.50) ALDH1A1USP2LMNAGAAMEN1
SCHEMBL10131745 0.69 NPC1 (0.53) ALDH1A1USP2LMNAGAAMEN1
SCHEMBL4757162 0.68 ALDH1A1 (0.40) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL4757510 0.68 ALDH1A1 (0.50) ALDH1A1USP2LMNAGAAMEN1
SCHEMBL10114546 0.68 LMNA (0.41) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL4756885 0.68 LMNA (0.40) ALDH1A1LMNAGAAMEN1KMT2A
SCHEMBL5836421 0.67 ALDH1A1 (0.68) ALDH1A1USP2LMNAGAAMEN1
SCHEMBL4756940 0.67 GPR27 (0.40) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL4757526 0.67 ALDH1A1 (0.48) ALDH1A1USP2LMNAGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC ALDH1A1 1605/4885USP2 3480/4885LMNA 2943/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC ALDH1A1 1605/4885USP2 3480/4885LMNA 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.